Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders. (Q34533734)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

S Smeland

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

C Müller

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T A Alvegard

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T Wiebe

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

O Björk

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A E Stenwig

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

H Willén

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T Holmström

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G Follerås

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

O Brosjö

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A Kivioja

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

K Jonsson

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

O Monge

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G Saeter

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 March 2003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

European Journal of Cancer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

39

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

488-494

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in osteosarcoma: a critical review.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarter

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of serum alkaline phosphatase measurements in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of dose-intensity in neoadjuvant chemotherapy of osteosarcoma: a retrospective analysis of high-dose methotrexate, cisplatinum and adriamycin used preoperatively

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor size and prognosis in aggressively treated osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum methotrexate (MTX) concentrations and prognosis in patients with osteosarcoma of the extremities treated with a multidrug neoadjuvant regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognosis in osteosarcoma: Norwegian National Data

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900747-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(02)00747-5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12751380%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34533734&oldid=1612007377"